Intraoperative Strategies for Transfusion-Free Surgery

Transfusion-Free Medicine and Surgery

Volumn , Issue , 2007, Pages 75-113

  Tobias, Joseph D ^a,b,c  

^a Department of Anesthesiology ^*  (United States)

^b Division of Pediatric Anesthesiology   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

Author keywords

Acute isovolemic hemodilution; Intraoperative blood salvage; Intraoperative strategies; Pharmacologic agents; Preoperative autologous donation

Indexed keywords

EID: 84889623865     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470994788.ch4     Document Type: Chapter

References (151)

1. Guay J, Haig M, Lortie L et al. Predicting blood loss in surgery for idiopathic scoliosis. Can J Anaesth 1994; 41: 775-81.
2. Goodnough LT, Bercher ME, Kanter MH et al. Transfusion medicine: first of two parts - blood transfusion. N Engl J Med 1999; 340: 438-47.
3. Parshuram C, Doyle J, LauWet al. Transfusion-associated graft versus host disease. Pediatr Crit Care Med 2002; 3: 57-62.
4. Schriemer PA, Longnecker DE, Mintz PD. The possible immunosuppressive effects of perioperative blood transfusion in cancer patients. Anesthesiology 1988; 68: 422-8.
5. Taylor RT, Manganaro L, O'Brien J et al. Impact of allogeneic packed red blood cell transfusion on nosocomial infection rates in the critically ill patient. Crit Care Med 2002; 30: 2249-54.
6. Carson JL, Altman DG, Duff A et al. Risk of bacterial infection with allogeneic blood transfusion among patients undergoing hip fracture repair. Transfusion 1999; 39: 694-700.
7. Cote CJ, Drop LJ, Hoaglin DC et al. Ionized hypocalcemia after fresh frozen plasma administration to thermally injured children. Anesth Analg 1988; 67: 152-60.
8. Gall O, Aubineau JV, Berniere J et al. Analgesic effect of low-dose intrathecal morphine after spinal fusion in children. Anesthesiology 2001; 94: 447-52.
9. Kurz A, Sessler DI, Lenhardt R (for the Study of Wound Infection and Temperature Control Group). Perioperative normothermia to reduce the incidence of surgical wound-associated infection and shorten hospitalization. N Engl J Med 1996; 334: 1209-15.
10. Schmied H, Kurz A, Sessler D et al. Mild hypothermia increases blood loss and transfusion requirements during total hip arthroplasty. Lancet 1996; 347: 289-92.
11. Cosgriff N, Moore EE, Sauaia A et al. Predicting life-threatening coagulopathy in the massively transfused trauma patient: hypothermia and acidosis revisited. J Trauma 1997; 42: 857-61.
12. Winkler M, Akca O, Birkenberg B et al. Aggressive warming reduces blood loss during hip arthroplasty. Anesth Analg 2000; 91: 978-84.
13. Widman J, Hammarqvist F, Sellden E. Amino acid infusion induces thermogenesis and reduces blood loss during hip arthroplasty under spinal anesthesia. Anesth Analg 2002; 95: 1757-62.
14. Ruttmann TG, James MF, Viljoen JF. Haemodilution induces a hypercoagulable state. Br J Anaesth 1996; 76: 412-14.
15. Karoutsos S, Nathan N, Lahrimi A et al. Thromboelastogram reveals hypercoagulability after administration of gelatin solution. Br J Anaesth 1999; 82: 175-7.
16. de Jonge E, Levi M, Berends F et al. Impaired haemostais by intravenous administration of a gelatin-based plasma expander in human subjects. Thromb Haemost 1998; 79: 286-90.
17. Mardel SN, Saunders FM, Allen H et al. Reduced quality of clot formation with gelatin-based plasma substitutes. Br J Anaesth 1998; 80: 204-7.
18. Ruttmann TG, James MFM, Aronson I. In vivo investigation into the effects of haemodilution with hydroxyethyl starch (200/0.5) and normal saline on coagulation. Br J Anaesth 1998; 80: 612-16.
19. Gross JB. Estimating allowable blood loss: corrected for dilution. Anesthesiology 1983; 58: 277-80.
20. Weber TP, Hartlage AG, Aken HV, Booke M. Anaesthetic strategies to reduce perioperative blood loss in paediatric surgery. Eur J Anaesth 2003; 20: 175-81.
21. Korosue K, Heros RC, Oglivy CS et al. Comparison of crystalloids and colloids for hemodilution in a model of focal cerebral ischemia. J Neurosurg 1990; 73: 576-84.
22. Davies MJ. The role of colloids in blood conservation. Int Anesthesiol Clin 1990; 28: 205-9.
23. Stump DC, Strauss RG, Henricksen RA et al. Effects of hydroxy-ethyl starch on blood coagulation, particularly factor VIII. Transfusion 1985; 25: 349-54.
24. Strauss RG, Stansfield C, Henriksen RA, Villhauer PJ. Pentastarch may cause fewer effects on coagulation than hetastarch. Transfusion 1988; 25: 257-60.
25. Renck H, Ljungstrom KG, Resberg B et al. Prevention of dextran-induced anaphylactic reactions by hapten inhibition. Acta Chir Scand 1983; 149: 349-53.
26. Glick G, Plauth WH, Braunwald E. Role of the autonomic nervous system in the circulatory response to acutely induced anemia in unanesthetized dogs. J Clin Invest 1964; 43: 2112-24.
27. Van Woerkins J, Trouborst A, Duncker DJ. Catecholamines and regional hemodynamics during isovolemic hemodilution alone and in combination with adenosineinduced controlled hypotension. J Appl Phys 1992; 72: 760-9.
28. Guyton AC, Richardson TQ. Effect of hematocrit on venous return. Circ Res 1961; 9: 157-65.
29. Crystal GJ, Rooney MW, Salem MR. Regional hemodynamics and oxygen supply during isovolemic hemodilution alone and in combination with adenosine-induced controlled hypotension. Anesth Analg 1988; 67: 211-18.
30. Laks H, Pilon RN, Klovekorn WP et al. Acute normovolemic hemodilution: effects on hemodynamics, oxygen, transport, and lung water in anesthetized man. Surg Forum 1974; 180: 103-9.
31. Bowens C, Spahn DR, Frasco PE et al. Hemodilution induces stable changes in global cardiovascular and regional myocardial function. Anesth Analg 1993; 76: 1027-32.
32. Tarnow J, Eberlein HJ, Hess E et al. Hemodynamic interactions of hemodilution anaesthesia, propranolol pretreatment and hypovolemia - I: systemic circulation. Basic Res Cardiol 1979; 74: 109-22.
33. Robertie PG, Gravlee GP. Safe limits of isovolemic hemodilution and recommendation for erythrocyte transfusion. Int Anesthesiol Clin 1990; 28: 197-203.
34. Fontana JL, Welborn L, Mongan PD et al. Oxygen consumption and cardiovascular function in children during profound intraoperative normovolemic hemodilution. Anesth Analg 1995; 80: 219-25.
35. Van der Linden P, De Hert S, Mathieu N et al. Tolerance to acute hemodilution: effect of anesthetic depth. Anesthesiology 2003; 99: 97-104.
36. Gillies IDS. Anemia and anaesthesia. Br J Anaesth 1974; 46: 589-602.
37. Sunder-Plassman L, Kessler M, Jesch F. Acute normovolemic hemodilution: changes in tissue oxygen supply and hemoglobin-oxygen affinity. Bibl Haematol 1975; 41: 44-53.
38. Holtz J, Bassenge E, von Restoriff W et al. Transmural differences in myocardial blood flow and in coronary dilatory capacity in hemodiluted conscious dogs. Basic Res Cardiol 1976; 71: 36-46.
39. Jan KM, Chien S. Effect of hematocrit variations on coronary hemodynamics and oxygen utilization. Am J Physiol 1977; 233: H106-H113.
40. Messmer K. Hemodilution. Surg Clin North Am 1975; 55: 659-78.
41. Buckberg G, Brazier J. Coronary blood flow and cardiac function during hemodilution. Bibl Haematol 1975; 41: 173-5.
42. Crystal GJ. Coronary hemodynamic responses during acute hemodilution in canine hearts. Am J Physiol 1988; 254: H525-H531.
43. Geha AS, Baue AE. Graded coronary stenosis and coronary flow during acute normovolemic anemia. World J Surg 1978; 2: 645.
44. Spahn DR, Smith LR, McRae RL, Leone BJ. Effects of acute isovolemic hemodilution and anesthesia on regional function in left ventricular myocardium with compromised coronary blood flow. Acta Anaesthesiol Scand 1992; 36: 628-36.
45. Kim YD, Katz NM, Ng L et al. Effects of hypothermia and hemodilution on oxygen metabolism and hemodynamics in patients recovering from coronary artery bypass operations. J Thorac Cardiovasc Surg 1989; 97: 36-42.
46. Weisel RD, Charlesworth DC, Mickleborough LL et al. Limitations of blood conservation. J Thorac Cardiovasc Surg 1984; 88: 26-38.
47. Todd MM, Weeks JB, Warner DS. Cerebral blood flow, blood volume and brain tissue hematocrit during isovolemic hemodilution with hetastarch in rats. Am J Physiol 1992; 263: H75-H82.
48. Pohl U, Busse R. Hypoxia stimulates release of endothelial-derived relaxant factor. Am J Physiol 1989; 256: H1595-H1600.
49. Fan FC, Chen RY, Schuessler GB et al. Effects of hematocrit variations on regional hemodynamics and oxygen transport in the dog. Am J Physiol 1980; 238: H545-H552.
50. Kessler M, Messmer K. Tissue oxygenation during hemodilution. Bibl Haematol 1975; 41: 16-33.
51. Biernat S, Kulig A, Lepert R et al. Pathomorphologic and histochemical changes in the liver during hemodilution. Am J Surg 1974; 128: 24-30.
52. Utley JR, Wachtel C, Cain RB et al. Effects of hypothermia, hemodilution and pump oxygenation on organ water content, blood flow, oxygen delivery and renal function. Ann Thorac Surg 1981; 31: 121-33.
53. Rand PW, Lacombe E. Viscosity of normal human blood under normothermic and hypothermic conditions. J Appl Phys 1964; 19: 117-22.
54. Olsfanger D, Jedeikin R, Metser H et al. Acute normovolemic hemodilution and idiopathic scoliosis surgery: effects on homologous blood requirements. Anesth Intens Care 1993; 21: 429-31.
55. Haberken M, Dangel P. Normovolemic hemodilution and intraoperative autotransfusion in children: experience with 30 cases of spinal fusion. Eur J Pediatr Surg 1991; 1: 30-55.
56. Stein JI, Gombotz H, Rigoler B et al. Open heart surgery in children of Jehovah's Witnesses: extreme hemodilution on cardiopulmonary bypass. Pediatr Cardiol 1991; 12: 170-4.
57. Spence RK, Carson JA, Poses RM et al. Elective surgery without transfusion: influence of preoperative hemoglobin level and blood loss on mortality. Am J Surg 1990; 159: 320-4.
58. Carson JA, Spence RK, Poses RM et al. Severity of anemia and operative mortality and morbidity. Lancet 1988; 157: 727-9.
59. Monk TG, Goodnough LT, Brecher ME et al. A prospective randomized comparison of three blood conservation strategies for radical prostatectomy. Anesthesiology 1999; 91: 24-33.
60. Fantus B. Blood preservation. JAMA 1937; 109: 128-31.
61. Stehling L. Autologous transfusion. Int Anesthesiol Clin 1990; 28: 190-6.
62. Mann M, Sacks HJ, Goldfinger D. Safety of autologous blood donation prior to elective surgery for a variety of potentially "high-risk"patients. Transfusion 1983; 23: 229-32.
63. Scott WJ, Rede R, Castleman B. Efficacy, complications and cost of a comprehensive blood conservation program for cardiac operations. J Thorac Cardiovasc Surg 1992; 103: 1001-7.
64. Owings DV, Kruskall MS, Therier RL et al. Autologous blood donations prior to elective cardiac surgery: safety and effect on subsequent blood use. JAMA 1989; 262: 1963-8.
65. DePelma L, Luban NLC. Autologous blood transfusion in pediatrics. Pediatrics 1990; 85: 125-8.
66. Klimber IW. Autotransfusion and blood conservation in oncologic surgery. Semin Surg Oncol 1989; 5: 286-92.
67. Tate DE, Friedmen RJ. Blood conservation in spinal surgery: review of current techniques. Spine 1992; 17: 1450-6.
68. Silvergleid DJ. Safety and effectiveness of predeposit autologous transfusion in preteen and adolescent children. JAMA 1987; 257: 3403-4.
69. Popovsky MA, Whitaker B, Arnold NL. Severe outcomes of allogeneic and autologous blood donation: frequency and characterization. Transfusion 1995; 35: 734-7.
70. Haugen R, Hill G. A large-scale autologous blood program in a community hospital. JAMA 1987; 257: 1211-14.
71. Goldfinger D, Capen S, Czer L et al. Safety and efficacy of preoperative donation of blood for autologous use by patients with end-stage heart or lung disease who are awaiting organ transplantation. Transfusion 1993; 33: 336-40.
72. Goodnough LT, Marcus RE. Effect of autologous blood donation in patients undergoing elective spine surgery. Spine 1992; 17: 172-5.
73. McVay PA, Hoag RW, Hoag MS et al. Safety and use of autologous blood donation during the third trimester of pregnancy. Am J Obstet Gynecol 1989; 160: 1479-88.
74. Davis R. Banked autologous blood for caesarean section. Anaesth Intens Care 1979; 7: 358-61.
75. Goodnough L, Wasmen J. Limitations to donating adequate autologous blood prior to elective surgery. Arch Surg 1989; 124: 494-6.
76. Goodnough L, Rudnick S, Price TH et al. Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy. N Engl J Med 1989; 321: 1163-8.
77. Goh M, Kleer CG, Kielczewski P et al. Autologous blood donation prior to anatomical radical retropubic prostatectomy: is it necessary? Urology 1997; 49: 569-73.
78. AuBuchon JP. Autologous transfusion and directed donations: current controversies and future directions. Transfus Med Rev 1989; 3: 290-306.
79. Duncan J. On reinfusion of blood in primary and other amputations. Br Med J 1886; 1: 192-7.
80. Rubens FD, Boodhwani M, Lavalee G et al. Perioperative red blood cell salvage. Can J Anaesth 2003; 50: S31-S40.
81. Gardner A, Gibbs M, Evans C et al. Relative cost of autologous red cell salvage versus allogeneic red cell transfusion during abdominal aortic aneurysm repair. Anaesth Intens Care 2000; 28: 646-9.
82. Solomon MD, Rutledge ML, Kane LE et al. Cost comparison of intraoperative autologous versus homologous transfusion. Transfusion 1988; 28: 379.
83. Dale RF, Kipling RM, Smith MF et al. Separation of malignant cells during autotransfusion. Br J Surg 1988; 75: 581.
84. Robicseck F, Duncan GD, Born GVR et al. Inherent dangers of simultaneous application of microfibrillar collagen hemostat and blood saving devices. J Thorac Cardiovasc Surg 1986; 92: 766-8.
85. Murray DJ, Gress K, Weinstein SL. Coagulopathy after reinfusion of autologous scavenged red blood cells. Anesth Analg 1992; 75; 125-9.
86. Wheeler TJ, Tobias JD. Complications of autotransfusion with salvaged blood. J Post Anesth Nurs 1994; 9: 150-2.
87. Bull MH, Bull BS, Van Arsdell GS, Smith LL. Clinical implications of procoagulant and leukoattractant formation during intraoperative blood salvage. Arch Surg 1988; 123: 1073-6.
88. O'Riordan WD. Autotransfusion in the emergency department of a community hospital. JACEP 1977; 6: 233-7.
89. Linden JV, Kaplan HS, Murphy MT. Fatal air embolism due to perioperative blood recovery. Anesth Analg 1997; 84: 422-6.
90. Symbas PN. Extraoperative autotransfusion from hemothorax. Surgery 1978; 84: 722-7.
91. Litwin MS, Relihan M, Olsen RE. Pulmonary microemboli associated with massive transfusion. Ann Surg 1975; 181: 51-7.
92. Mattox KL. Autotransfusion in the emergency department. JACEP 1975; 4: 218-22.
93. Horst HM, Dlugos S, Fath JJ et al. Coagulopathy and intraoperative blood salvage. J Trauma 1992; 32: 646-53.
94. Halpern NA, Alicea M, Seabrook B et al. Cell saver autologous transfusion: metabolic consequences of washing blood with normal saline. J Trauma 1996; 41: 407-15.
95. Halpern NA, Alicea M, Seabrook B et al. Isolyte S, a physiologic multielectrolyte solution, is preferable to normal saline to wash cell saver salvaged blood: conclusions from a prospective, randomized study in a canine model. Crit Care Med 1997; 25: 2031-8.
96. Richardson DW, Robinson HG. Desmopressin. Ann Intern Med 1985; 103: 228.
97. Mannucci PM. Desmopressin: a non-transfusional form of treatment for congenital and acquired bleeding disorders. Blood 1988; 72: 1449-55.
98. Horrow JC. Desmopressin and antifibrinolytics. Int Anesthesiol Clin 1990; 28: 230-5.
99. Salva KM, Kim HC, Nahum K et al. DDAVP in the treatment of bleeding disorders. Pharmacotherapy 1988; 8: 94-9.
100. Mannucci PM, Vicenti V, Alberca I et al. Intravenous and subcutaneous administration of desmopressin (DDAVP) to hemophiliacs: pharmacokinetics and factor VIII responses. Thromb Haemost 1987; 58: 1037-9.
101. Lethagen S, Harris AS, Sjorin E, Nilsson IM. Intranasal and intravenous administration of desmopressin: effect on FVIII/vWF, pharmacokinetics and reproducibility. Thromb Haemost 1987; 58: 1033-6.
102. Salzman EW, Weinstein MJ, Weintraub RM et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. N Engl J Med 1986; 314: 1402-6.
103. Czer LSC, Bateman TM, Gray RJ et al. Treatment of severe platelet dysfunction and hemorrhage after cardiopulmonary bypass: reduction in blood product usage with desmopressin. J Am Coll Cardiol 1987; 9: 1139-47.
104. Mannucci PM, Remuzzi G, Pusineri F et al. Desamino-8-D-arginine vasopressin shortens the bleeding time in uremia. N Engl J Med 1983; 308: 8-12.
105. Mannucci PM, Vicente V, Vianello L et al. Controlled trial of a desmopressin in liver cirrhosis and other conditions associated with a prolonged bleeding time. Blood 1986; 67: 1148-53.
106. Kobrinsky NL, Letts RM, Patel LR et al. 1-Desamino-8-D-arginine vasopressin (desmopressin) decreases operative blood loss in patients having Harrington rod spinal fusion surgery. Ann Intern Med 1987; 107: 446-50.
107. Theroux MC, Corddry DH, Tietz AE et al. A study of desmopressin and blood loss during spinal fusion for neuromuscular scoliosis: a randomized, controlled, double-blinded study. Anesthesiology 1997; 87: 260-7.
108. Alanay A, Acaroglu E, Oxdemir O et al. Effects of deamino-8-D-arginine vasopressin on blood loss and coagulation factors in scoliosis surgery. Spine 1999; 9: 877-82.
109. Seear MD, Wadsworth LD, Rogers PC. The effect of desmopressin acetate (DDAVP) on postoperative blood loss after cardiac operations in children. J Thorac Cardiovasc Surg 1989; 98: 217-19.
110. Laupacis A, Fergusson D. Drugs to minimize perioperative blood loss in cardiac surgery: meta-analysis using perioperative blood transfusion as the outcome. The international study of perioperative transfusion (ISPOT) investigators. Anesth Analg 1997; 85: 1258-67.
111. Levi M, Cromheecke ME, de Jonge E et al. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints. Lancet 1999; 354: 1940-7.
112. Florentino-Pineda I, Blakemore LC, Thompson GH et al. The effect of epsilonaminocaproic acid on perioperative blood loss in patients with idiopathic scoliosis undergoing posterior spinal fusion. Spine 2001; 26: 1147-51.
113. Neilipovitz DT, Murto K, Hall L et al. A randomized trial of tranexamic acid to reduce blood transfusion for scoliosis surgery. Anesth Analg 2001; 93: 82-7.
114. Hippala S, Strid L, Wennerstrand MI et al. Tranexamic acid reduces perioperative blood loss associated with total knee arthroplasty. Br J Anaesth 1995; 74: 534-7.
115. Hippala S, Strid LJ, Wennerstrand MI et al. Tranexamic acid radically decreases blood loss and transfusions associated with total knee arthroplasty. Anesth Analg 1997; 84: 839-44.
116. Benoni G, Fredin H. Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomized double blind study of 86 patients. J Bone Joint Surg Br 1996; 78: 434-40.
117. Boylan JF, Klinck JR, Sandler AN et al. Tranexamic acid reduces blood loss, transfusion requirements and coagulation factor use in primary orthotopic liver transplantation. Anesthesiology 1996; 85: 1043-8.
118. Sack E, Spaet TH, Gentile R et al. Reduction of prostatectomy bleeding by epsilonaminocaproic acid. N Engl J Med 1962; 266: 541-64.
119. DelRossi AJ, Cernaianu AC, Botros S et al. Prophylactic treatment of postperfusion bleeding using EACA. Chest 1989; 96: 27-30.
120. Horrow JC, Hlavecek J, Strong MD et al. Prophylactic tranexamic acid decreases bleeding after cardiac operations. J Thorac Cardiovasc Surg 1990; 99: 70-4.
121. Ovrum E, Holen EA, Abdelnoor M et al. Tranexamic acid is not necessary to reduce blood loss after coronary artery bypass operations. J Thorac Cardiovasc Surg 1993; 105: 78-83.
122. Amar D, Grant FM, Zhang H et al. Antifibrinolytic therapy and perioperative blood loss in cancer patients undergoing major orthopedic surgery. Anesthesiology 2003; 98: 337-42.
123. Wells PS. Safety and efficacy of methods for reducing perioperative allogeneic transfusion: a critical review. Am J Therap 2002; 9: 377-88.
124. Royston D, Taylor KM, Sapsford RN, Bidstup BP. Effect of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet 1987; 2: 1289-91.
125. Urban MK, Beckman J, Gordon M et al. The efficacy of antifibrinolytics in the reduction of blood loss during complex adult reconstructive spine surgery. Spine 2001; 26: 1152-7.
126. Capdevila X, Calvet Y, Biboulet P et al. Aprotinin decreases blood loss and homologous transfusions in patients undergoing major orthopedic surgery. Anesthesiology 1998; 88: 50-7.
127. Janssens M, Joris J, David JL et al. High-dose aprotinin reduces blood loss in patients undergoing total hip replacement surgery. Anesthesiology 1994; 80: 23-9.
128. Bidstrup BP, Harrison J. Royston D et al. Aprotinin therapy in cardiac operations: a report on use in 41 cardiac centers in the United Kingdom. Ann Thorac Surg 1993; 55: 971-6.
129. Kalicinski P, Kaminski A, Drewniak T et al. Quick correction of hemostasis in two patients with fulminant liver failure undergoing liver transplantation by recombinant activated factor VII. Transplant Proc 1999; 31: 378-9.
130. Tobias JD, Berkenbosch JW. Synthetic factor VIIa concentrate to treat coagulopathy and gastrointestinal bleeding in an infant with end-stage liver disease. Clin Pediatr 2002; 41: 613-16.
131. Tobias JD, Groeper K, Berkenbosch JW. Preliminary experience with the use of recombinant factor VIIa to treat coagulation disturbances in pediatric patients. South Med J 2003; 96: 12-16.
132. Martinowitz U, Kenet G, Segal E et al. Recombinant factor VII for adjunctive hemorrhage control in trauma. J Trauma 2001; 51: 431-9.
133. Hendriks HGD, Meijer K, de Wolf JT et al. Reduced transfusion requirements by recombinant factor VIIa in orthotopic liver transplantation. Transplantation 2001; 71: 402-5.
134. Murkin JM. A novel hemostatic agent: the potential role of recombinant activated factor VII in anesthetic practice. Can J Anaesth 2002; 49: S21-S26.
135. Tobias JD. Synthetic factor VIIa to treat dilutional coagulopathy during posterior spinal fusion in two children. Anesthesiology 2002; 96: 1522-5.
136. Friederich PW, Henny CP, Messelink EJ et al. Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind place-controlled randomized trial. Lancet 2002; 36: 201-5.
137. Roberts HR. Recombinant factor VIIa (NovoSeven) and the safety of treatment. Semin Hematol 2001; 38: 48-50.
138. Roberts HR. Clinical experience with activated factor VII: focus on safety aspects. Blood Coag Fibrin 1998; 9: S115-S118.
139. Gallisti S, Cvrin G, Muntean W. Recombinant factor VIIa does not induce hypercoagulability in vitro. Thromb Haemost 1999; 81: 245-9
140. Meneghini L, Zadra N, Anloni V et al. Erythropoietin therapy and acute preoperative normovolemic haemodilution in infants undergoing craniosynostosis surgery. Paediatr Anaesth 2003; 13: 392-6.
141. Eckenhoff JE, Rich JC. Clinical experiences with deliberate hypotension. Anesth Analg 1966; 45: 21-8.
142. Sollevi A. Hypotensive anesthesia and blood loss. Acta Anaesth Scand 1988; 89(Suppl.): 39-43.
143. Sperry RJ, Monk CR, Durieux ME et al. The influence of hemorrhage on organ perfusion during deliberate hypotension in rats. Anesthesiology 1992; 77: 1171-7.
144. Seyde WC, Longnecker DE. Cerebral oxygen tension in rats during deliberate hypotension with sodium nitroprusside, 2-chloroadenosine or deep isoflurane anesthesia. Anesthesiology 1986; 64: 480-5.
145. Ringaert KRA, Mutch WAC, Malo LA. Regional cerebral blood flow and response to carbon dioxide during controlled hypotension with isoflurane anesthesia in the rat. Anesth Analg 1988; 67: 383-8.
146. Fukusaki M, Hara MT, Maekawa T et al. Effects of controlled hypotension with sevoflurane anaesthesia on hepatic function of surgical patients. Eur J Anaesthesiol 1999; 16: 111-16.
147. Sivarajan M, Amory DW, Everett GB et al. Blood pressure, not cardiac output, determines blood loss during induced hypotension. Anesth Analg 1980; 59: 203-6.
148. Hines R, Barash P. Infusion of sodium nitroprusside induces platelet dysfunction in vitro. Anesthesiology 1989; 70: 611-15.
149. Bernard JM, Passuti N, Pinaud M. Long-term hypotensive technique with nicardipine and nitroprusside during isoflurane anesthesia for spinal surgery. Anesth Analg 1992; 72: 179-85.
150. Bernard JM, Pinaud M, Francois T et al. Deliberate hypotension with nicardipine or nitroprusside during total hip arthroplasty. Anesth Analg 1991; 73: 341-5.
151. Hersey SL, O'Dell NE, Lowe S et al. Nicardipine versus nitroprusside for controlled hypotension during spinal surgery in adolescents. Anesth Analg 1997; 84: 1239-44.